Dr. Bilal Farooqi, MD

Dr. Farooqi practices at Good Samaritan Hospital in Suffern, New York, part of Westchester Medical Center Health Network.

Dr. Farooqi's NPI, 1467891333, was assigned on June 24, 2013. Dr. Farooqi holds New York license 331055.

Dr. Farooqi's primary practice is Good Samaritan Hospital, at 255 Lafayette Avenue, Suffern, NY 10901 in Rockland County. The practice phone is (914) 368-5000.

Dr. Farooqi's primary practice is Good Samaritan Hospital in Suffern, New York, part of Westchester Medical Center Health Network. Dr. Farooqi is also affiliated with Westchester Medical Center. The medical group on file is Westchester Medical Center Advanced Physician Services. Dmand AI also links Dr. Farooqi to 1 more hospital, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Farooqi practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Farooqi's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Farooqi's licenses on file in 4 states: New York, Florida, Georgia and New Jersey.

CMS data shows 2,366 Medicare services from Dr. Farooqi across 26 procedure codes in 2024, for 241 Medicare patients. Medicare paid $92,524 for them.

CMS counts 241 Medicare patients who saw Dr. Farooqi in 2024. The largest group is 75 to 84, with 103 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Farooqi's median patient age at 74, with 54% women.

In 2024, Dr. Farooqi wrote 364 Medicare Part D claims for 97 patients. 53% of them were for generic drugs. CMS names the drug for 179 of them, across 5 drugs with 11 or more claims each, at $905,000 in total drug cost. In 2023, CMS named 119 claims across 6 drugs.

Dr. Farooqi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Farooqi as offering telehealth.

Dmand AI links 10 papers to Dr. Farooqi, published from 2015 to 2022. 2015 was the busiest year, with 2. Dr. Farooqi's most frequent co-authors are Hemant Goyal, MD, Anthony Paul Cannella, MD and Yasna Chaudhary, MD.

CMS Open Payments shows 166 general payments to Dr. Farooqi from 43 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 59% of the total. Celgene Corporation paid the most, $2,010.